1887

Abstract

The IFN immune system plays an essential role in protecting the host against most viral infections. In order to explore the interactions between the IFN pathway and human respiratory syncytial virus (RSV) infection, and to identify potential IFN-stimulated genes (ISGs) that may be involved in suppressing the replication of RSV, we utilized an IFN pathway-specific microarray to study the effects of RSV infection on the IFN pathway in HeLa cells. We showed that RSV infection enhanced the expression of a series of ISGs, including oligoadenylate synthetase 2, IFITM1 (IFN-induced transmembrane protein 1) and myxovirus resistance 2. Our results also showed that the IFITM proteins potently inhibited RSV infection mainly by interfering with both virus entry and the subsequent replication steps, but not the attachment process. The antiviral effect of IFITM3 was not affected by ubiquitination modification. Furthermore, knocking down the endogenous and IFN-induced expression of IFITM1 and 3 facilitated RSV infection. Expression of the IFITM proteins was found to delay the phosphorylation of IFN regulatory factor 3 through interfering with the detection of viral RNA by MDA5 (melanoma differentiation-associated gene 5) and RIG-I (retinoic acid-inducible gene I). These results demonstrated that the restriction of RSV infection by the IFITM proteins was achieved through the inhibition of virus entry and replication, and they provided further insight for exploring the mechanism of IFITM-protein-mediated virus restriction.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.066555-0
2015-01-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/1/170.html?itemId=/content/journal/jgv/10.1099/vir.0.066555-0&mimeType=html&fmt=ahah

References

  1. Anafu A. A., Bowen C. H., Chin C. R., Brass A. L., Holm G. H.. ( 2013;). Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. . J Biol Chem 288:, 17261–17271. [CrossRef][PubMed]
    [Google Scholar]
  2. Brass A. L., Huang I. C., Benita Y., John S. P., Krishnan M. N., Feeley E. M., Ryan B. J., Weyer J. L., van der Weyden L.. & other authors ( 2009;). The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. . Cell 139:, 1243–1254. [CrossRef][PubMed]
    [Google Scholar]
  3. Diamond M. S., Farzan M.. ( 2013;). The broad-spectrum antiviral functions of IFIT and IFITM proteins. . Nat Rev Immunol 13:, 46–57. [CrossRef][PubMed]
    [Google Scholar]
  4. Everitt A. R., Clare S., Pertel T., John S. P., Wash R. S., Smith S. E., Chin C. R., Feeley E. M., Sims J. S.. & other authors ( 2012;). IFITM3 restricts the morbidity and mortality associated with influenza. . Nature 484:, 519–523. [CrossRef][PubMed]
    [Google Scholar]
  5. Everitt A. R., Clare S., McDonald J. U., Kane L., Harcourt K., Ahras M., Lall A., Hale C., Rodgers A.. & other authors ( 2013;). Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. . PLoS ONE 8:, e80723. [CrossRef][PubMed]
    [Google Scholar]
  6. Falsey A. R., Cunningham C. K., Barker W. H., Kouides R. W., Yuen J. B., Menegus M., Weiner L. B., Bonville C. A., Betts R. F.. ( 1995;). Respiratory syncytial virus and influenza A infections in the hospitalized elderly. . J Infect Dis 172:, 389–394. [CrossRef][PubMed]
    [Google Scholar]
  7. García-Sastre A., Biron C. A.. ( 2006;). Type 1 interferons and the virus–host relationship: a lesson in détente. . Science 312:, 879–882. [CrossRef][PubMed]
    [Google Scholar]
  8. Guerrero-Plata A., Baron S., Poast J. S., Adegboyega P. A., Casola A., Garofalo R. P.. ( 2005;). Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. . J Virol 79:, 10190–10199. [CrossRef][PubMed]
    [Google Scholar]
  9. Handforth J., Friedland J. S., Sharland M.. ( 2000;). Basic epidemiology and immunopathology of RSV in children. . Paediatr Respir Rev 1:, 210–214. [CrossRef][PubMed]
    [Google Scholar]
  10. Hsu N. Y., Ilnytska O., Belov G., Santiana M., Chen Y. H., Takvorian P. M., Pau C., van der Schaar H., Kaushik-Basu N.. & other authors ( 2010;). Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. . Cell 141:, 799–811. [CrossRef][PubMed]
    [Google Scholar]
  11. Huang I. C., Bailey C. C., Weyer J. L., Radoshitzky S. R., Becker M. M., Chiang J. J., Brass A. L., Ahmed A. A., Chi X. L.. & other authors ( 2011;). Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. . PLoS Pathog 7:, e1001258. [CrossRef][PubMed]
    [Google Scholar]
  12. Jewell N. A., Vaghefi N., Mertz S. E., Akter P., Peebles R. S. Jr, Bakaletz L. O., Durbin R. K., Flaño E., Durbin J. E.. ( 2007;). Differential type I interferon induction by respiratory syncytial virus and influenza A virus in vivo. . J Virol 81:, 9790–9800. [CrossRef][PubMed]
    [Google Scholar]
  13. Kolokoltsov A. A., Deniger D., Fleming E. H., Roberts N. J. Jr, Karpilow J. M., Davey R. A.. ( 2007;). Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. . J Virol 81:, 7786–7800. [CrossRef][PubMed]
    [Google Scholar]
  14. Krzyzaniak M. A., Zumstein M. T., Gerez J. A., Picotti P., Helenius A.. ( 2013;). Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. . PLoS Pathog 9:, e1003309. [CrossRef][PubMed]
    [Google Scholar]
  15. Lifland A. W., Jung J., Alonas E., Zurla C., Crowe J. E. Jr, Santangelo P. J.. ( 2012;). Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. . J Virol 86:, 8245–8258. [CrossRef][PubMed]
    [Google Scholar]
  16. Lin R. J., Yu H. P., Chang B. L., Tang W. C., Liao C. L., Lin Y. L.. ( 2009;). Distinct antiviral roles for human 2′,5′-oligoadenylate synthetase family members against dengue virus infection. . J Immunol 183:, 8035–8043. [CrossRef][PubMed]
    [Google Scholar]
  17. Ling Z. H., Tran K. C., Teng M. N.. ( 2009;). Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. . J Virol 83:, 3734–3742. [CrossRef][PubMed]
    [Google Scholar]
  18. Lo M. S., Brazas R. M., Holtzman M. J.. ( 2005;). Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. . J Virol 79:, 9315–9319. [CrossRef][PubMed]
    [Google Scholar]
  19. Lu J., Pan Q. H., Rong L. W., He W., Liu S. L., Liang C.. ( 2011;). The IFITM proteins inhibit HIV-1 infection. . J Virol 85:, 2126–2137. [CrossRef][PubMed]
    [Google Scholar]
  20. Magro M., Andreu D., Gómez-Puertas P., Melero J. A., Palomo C.. ( 2010;). Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein. . J Virol 84:, 7970–7982. [CrossRef][PubMed]
    [Google Scholar]
  21. McCarthy C. A., Hall C. B.. ( 2003;). Respiratory syncytial virus: concerns and control. . Pediatr Rev 24:, 301–309. [CrossRef][PubMed]
    [Google Scholar]
  22. Mudhasani R., Tran J. P., Retterer C., Radoshitzky S. R., Kota K. P., Altamura L. A., Smith J. M., Packard B. Z., Kuhn J. H.. & other authors ( 2013;). IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. . J Virol 87:, 8451–8464. [CrossRef][PubMed]
    [Google Scholar]
  23. Raychoudhuri A., Shrivastava S., Steele R., Kim H., Ray R., Ray R. B.. ( 2011;). ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. . J Virol 85:, 12881–12889. [CrossRef][PubMed]
    [Google Scholar]
  24. Sadler A. J., Williams B. R.. ( 2008;). Interferon-inducible antiviral effectors. . Nat Rev Immunol 8:, 559–568. [CrossRef][PubMed]
    [Google Scholar]
  25. Sen G. C.. ( 2001;). Viruses and interferons. . Annu Rev Microbiol 55:, 255–281. [CrossRef][PubMed]
    [Google Scholar]
  26. Weidner J. M., Jiang D., Pan X. B., Chang J., Block T. M., Guo J. T.. ( 2010;). Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. . J Virol 84:, 12646–12657. [CrossRef][PubMed]
    [Google Scholar]
  27. Yount J. S., Karssemeijer R. A., Hang H. C.. ( 2012;). S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. . J Biol Chem 287:, 19631–19641. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.066555-0
Loading
/content/journal/jgv/10.1099/vir.0.066555-0
Loading

Data & Media loading...

Supplementary Data



PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error